A combined analysis of two prospective randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastoma
Lucy Gately(Walter and Eliza Hall Institute of Medical Research), Carmen Balañá(Institut Català d'Oncologia), Sudeep S. Gill(Providence Health Care), Ross Jennens, Craig Underhill(AstraZeneca (United Kingdom)), Pedro Pérez‐Segura(Hospital Clínico San Carlos), Rosemary Harrup(University of Tasmania), Ian Collins(St. James's Hospital), Carlos Mesía(Institut Català d'Oncologia), Maria Martinez‐García(Hospital Del Mar), M. Alonso(Hospital Universitario Virgen del Rocío), Elizabeth Ahern(Monash Health), Peter Gibbs(The University of Melbourne), Anthony Dowling(Monash University), Sergio Peralta(Hospital Universitari Sant Joan de Reus), A. Long(Providence Portland Medical Center), Katharine Cuff(Eastern Health), Regina Gironés(Hospital Universitari i Politècnic La Fe), M Navarro(Instituto Ramón y Cajal de Investigación Sanitaria), M. Dumas(Walter and Eliza Hall Institute of Medical Research), Juan Manuel Sepúlveda-Sánchez(Hospital Universitario 12 De Octubre), Robert M. Campbell(Children's Health Queensland Hospital and Health Service), Óscar Gallego(Hospital de Sant Pau), Stephen Brown(Ballarat Health Services), Ana Herrero(Hospital Universitario Miguel Servet), J. Fuster(Hospital Universitario Son Espases), M. Rosenthal(Peter MacCallum Cancer Centre), Javier Torres(Goulburn Valley Health), Zarnie Lwin(The University of Queensland), M. Covela(Hospital Universitario Lucus Augusti), Adam Cooper(Liverpool Hospital), Estela Pineda(Hospital Clínic de Barcelona), Ma‐Li Wong(SUNY Upstate Medical University)
Cited by 5
Related Papers
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
Detection and localization of surgically resectable cancers with a multi-analyte blood test
|Science|2018|2.8k
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
|Nature Reviews Clinical Oncology|2020|1.9k
Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer
|Science Translational Medicine|2016|1.5k
Histone Modifications and Cancer
|Cold Spring Harbor Perspectives in Biology|2016|1.1k